billHR6407•Event Wednesday, December 3, 2025Analyzed

RCORP Authorization Act

Neutral

Summary

HR6407 (RCORP Authorization Act) is an early-stage bill that authorizes the Rural Communities Opioid Response Program but contains no specific funding amounts. It has been referred to committee with zero market-moving provisions or direct financial impact on any public company.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR6407 is an authorization-only bill with zero appropriated dollars—there is no money attached.
  • 2.The bill remains at the earliest legislative stage (referred to committee since Dec 2025) with minimal momentum.
  • 3.No publicly traded company is directly affected by this legislation; the grant program targets rural health networks and local entities.

Market Implications

No market implications. This bill does not affect any publicly traded company's revenue, costs, or competitive position. No tickers meet the causal chain threshold for inclusion.

Full Analysis

  1. On December 3, 2025, Rep. Carol Miller (R-WV) introduced HR6407 in the 119th Congress. The bill amends the Public Health Service Act to establish and maintain the Rural Communities Opioid Response Program (RCORP), a grant program administered by HRSA. The bill was referred to the House Committee on Energy and Commerce on the same day and has seen no further legislative action since introduction. 2) The bill contains no dollar figures. Authorization without appropriation means this is a policy framework, not a funding vehicle. Actual money for RCORP would require a separate appropriations bill. 3) Because the bill authorizes a grant program administered by a federal agency (HRSA) with no named beneficiaries, no formula for distribution, and no set dollar amount, there are zero specific companies that stand to benefit or lose from this legislation at this stage. The program targets rural health providers, community coalitions, and state/local governments—not publicly traded companies. 4) No real market data is provided for this event. 5) The legislative path is extremely early: the bill must clear committee, pass the House, pass the Senate, and be signed by the President. With only 6 cosponsors and no companion Senate bill, passage probability is low in the current session.

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →